- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03572439
Identification of the Sensory Level Block to Cold During Epidural Analgesia for Labor: A Cohort Study to Determine the Influence of the Direction of Testing
February 21, 2019 updated by: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Identification of the Sensory Level Block to Cold During Epidural Analgesia for Labor: A Cohort Study to Determine the Influence of the Direction of Testing (Anesthetized Area to Non-anesthetized Area Versus Non-anesthetized to Anesthetized Area)
Assessment of the upper sensory block level during neuraxial analgesia for labor and delivery is an essential component of clinical management and patient safety.
A variety of methods have been used for testing the sensory block such as cold, light touch, sharp touch or prick and transcutaneous electrical stimulation.
In addition to the diversity of methods, the endpoints used by investigators have also been variable, considering total or partial responses as endpoints.
Not surprisingly, a variable sensory block level could be identified as a result of the different methods and types of question asked by the examiner.
Another complicating factor is the lack of standardization of the direction of the testing as it relates to anesthetized and non-anesthetized areas.
This lack of standardization may result in a difference of several dermatomes in the level that two different assessors might record for the same patient.
Considering a clinical research scenario, it may be difficult to replicate results and implement clinical practices.
The objective of this study is to determine the degree of agreement between two methods of assessing the sensory block level to cold in women receiving epidural analgesia for labor (anesthetized to non-anesthetized segments versus non-anesthetized to anesthetized segments).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G1X5
- Mount Sinai Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- patients who request and have no contraindications to receive epidural analgesia
- capable of understanding and signing the written informed consent
- have no language barrier to respond to the level of sensory block assessment
- have no conditions that could compromise their sensitivity to cold.
Exclusion Criteria:
- patients who refuse to sign consent
- epidural analgesia is contraindicated
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Cephalad to caudal
Sensory block level check using ice, moving from cephalad to caudal
|
Patients are asked to report when the ice feels as cold as it does on the forehead.
|
|
Active Comparator: Caudal to cephalad
Sensory block level check using ice, moving from caudal to cephalad
|
Patients are asked to report when the ice feels as cold as it does on the forehead.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The lower sensory block level to cold
Time Frame: 1 hour
|
The sensory block level will be defined as: the dermatome at which and below which there is complete loss of sensation to cold
|
1 hour
|
|
The upper sensory block level to cold
Time Frame: 1 hour
|
The sensory block level will be defined as: the dermatome at which and below which there is still partial sensation to cold
|
1 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient satisfaction
Time Frame: 20 minutes
|
Patients will be asked to report satisfaction with the test done from 0-10 (0=very uncomfortable 10=most comfortable
|
20 minutes
|
|
The lower sensory block level to cold
Time Frame: 2 hours
|
The sensory block level will be defined as: the dermatome at which and below which there is complete loss of sensation to cold
|
2 hours
|
|
The upper sensory block level to cold
Time Frame: 2 hours
|
The sensory block level will be defined as: the dermatome at which and below which there is still partial sensation to cold
|
2 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 17, 2018
Primary Completion (Actual)
January 10, 2019
Study Completion (Actual)
January 10, 2019
Study Registration Dates
First Submitted
June 18, 2018
First Submitted That Met QC Criteria
June 18, 2018
First Posted (Actual)
June 28, 2018
Study Record Updates
Last Update Posted (Actual)
February 22, 2019
Last Update Submitted That Met QC Criteria
February 21, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 18-05
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.